rs148690740
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_144672.4(OTOA):c.1880+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000143 in 1,613,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_144672.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 22Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152118Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251262 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461640Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727134 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74300 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Identified in a patient with hearing loss in published literature, however, clinical and molecular data is not available (PMID: 34416374); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31589614, 34416374) -
- -
This sequence change affects a donor splice site in intron 17 of the OTOA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in OTOA are known to be pathogenic (PMID: 11972037). This variant is present in population databases (rs148690740, gnomAD 0.009%). Disruption of this splice site has been observed in individuals with deafness (PMID: 34416374; internal data). ClinVar contains an entry for this variant (Variation ID: 164826). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
OTOA-related disorder Pathogenic:1
The OTOA c.1880+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in the compound heterozygous state in an individual with hearing loss (Guan et al. 2021. PubMed ID: 34416374, supplementary data). This variant is reported in 0.012% of alleles in individuals of Latino descent in gnomAD. Variants that disrupt the consensus splice donor site in OTOA are expected to be pathogenic. This variant is interpreted as pathogenic. -
Autosomal recessive nonsyndromic hearing loss 22 Pathogenic:1
- -
Rare genetic deafness Pathogenic:1
The 1880+1G>A variant OTOA has not been previously reported in individuals with hearing loss but has been identified in 1/4396 African American chromosomes and 1/8600 European American chromosomes by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu; dbSNP rs148690740). This variant occurs in the invaria nt region (+/- 1/2) of the splice consensus sequence and is predicted to cause a ltered splicing leading to an abnormal or absent protein. In summary, this varia nt meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/ LMM). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at